The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Nanotechnology Drug Delivery-Global Market Insights and Sales Trends 2024
Synopsis
Nano-technology field has a potential to make significant impact on healthcare by delivering disease diagnosis, monitoring, implants, regenerative medicines and drug delivery, drug discovery for biomedicine. Since last few years, significant progress has been made in the field of nano-medicine (i.e. nano-technology), resulting in a number of products, including therapeutics and imaging agents, enabling more effective and less toxic therapeutic and diagnostic interventions.
The global Nanotechnology Drug Delivery market size is expected to reach US$ 5421.1 million by 2029, growing at a CAGR of 2.5% from 2023 to 2029. The market is mainly driven by the significant applications of Nanotechnology Drug Delivery in various end use industries. The expanding demands from the Neurology, Oncology, Cardiovascular/Physiology and Anti-inflammatory/Immunology, are propelling Nanotechnology Drug Delivery market. Nanocrystals, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Nanoparticles segment is estimated at % CAGR for the next seven-year period.
Nanotechnology drug delivery is a growing field and is witnessing increasing acceptance in health care applications. Nanotechnology drug delivery is widely used in the health care industry in applications such as neurology, anti-infective, cardiovascular disorders, and others. One important and active application area of nanotechnology drug delivery systems is to transport drugs to the final location of therapeutic intervention within the body.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nanotechnology Drug Delivery, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Nanotechnology Drug Delivery market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Nanotechnology Drug Delivery market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nanotechnology Drug Delivery sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Nanotechnology Drug Delivery covered in this report include AbbVie, Amgen, Celgene, Johnson & Johnson, Merck & Co., Novartis International, Perrigo Company, Pfizer and Teva Pharmaceutical Industries, etc.
The global Nanotechnology Drug Delivery market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AbbVie
Amgen
Celgene
Johnson & Johnson
Merck & Co.
Novartis International
Perrigo Company
Pfizer
Teva Pharmaceutical Industries
Global Nanotechnology Drug Delivery market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nanotechnology Drug Delivery market, Segment by Type:
Nanocrystals
Nanoparticles
Liposomes
Micelles
Nanotubes
Others
Global Nanotechnology Drug Delivery market, by Application
Neurology
Oncology
Cardiovascular/Physiology
Anti-inflammatory/Immunology
Anti-infective
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Nanotechnology Drug Delivery companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Nano-technology field has a potential to make significant impact on healthcare by delivering disease diagnosis, monitoring, implants, regenerative medicines and drug delivery, drug discovery for biomedicine. Since last few years, significant progress has been made in the field of nano-medicine (i.e. nano-technology), resulting in a number of products, including therapeutics and imaging agents, enabling more effective and less toxic therapeutic and diagnostic interventions.
The global Nanotechnology Drug Delivery market size is expected to reach US$ 5421.1 million by 2029, growing at a CAGR of 2.5% from 2023 to 2029. The market is mainly driven by the significant applications of Nanotechnology Drug Delivery in various end use industries. The expanding demands from the Neurology, Oncology, Cardiovascular/Physiology and Anti-inflammatory/Immunology, are propelling Nanotechnology Drug Delivery market. Nanocrystals, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Nanoparticles segment is estimated at % CAGR for the next seven-year period.
Nanotechnology drug delivery is a growing field and is witnessing increasing acceptance in health care applications. Nanotechnology drug delivery is widely used in the health care industry in applications such as neurology, anti-infective, cardiovascular disorders, and others. One important and active application area of nanotechnology drug delivery systems is to transport drugs to the final location of therapeutic intervention within the body.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nanotechnology Drug Delivery, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Nanotechnology Drug Delivery market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Nanotechnology Drug Delivery market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nanotechnology Drug Delivery sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Nanotechnology Drug Delivery covered in this report include AbbVie, Amgen, Celgene, Johnson & Johnson, Merck & Co., Novartis International, Perrigo Company, Pfizer and Teva Pharmaceutical Industries, etc.
The global Nanotechnology Drug Delivery market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AbbVie
Amgen
Celgene
Johnson & Johnson
Merck & Co.
Novartis International
Perrigo Company
Pfizer
Teva Pharmaceutical Industries
Global Nanotechnology Drug Delivery market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nanotechnology Drug Delivery market, Segment by Type:
Nanocrystals
Nanoparticles
Liposomes
Micelles
Nanotubes
Others
Global Nanotechnology Drug Delivery market, by Application
Neurology
Oncology
Cardiovascular/Physiology
Anti-inflammatory/Immunology
Anti-infective
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Nanotechnology Drug Delivery companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Nanotechnology Drug Delivery
1.1 Nanotechnology Drug Delivery Market Overview
1.1.1 Nanotechnology Drug Delivery Product Scope
1.1.2 Nanotechnology Drug Delivery Market Status and Outlook
1.2 Global Nanotechnology Drug Delivery Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Nanotechnology Drug Delivery Market Size by Region (2018-2029)
1.4 Global Nanotechnology Drug Delivery Historic Market Size by Region (2018-2023)
1.5 Global Nanotechnology Drug Delivery Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Nanotechnology Drug Delivery Market Size (2018-2029)
1.6.1 North America Nanotechnology Drug Delivery Market Size (2018-2029)
1.6.2 Europe Nanotechnology Drug Delivery Market Size (2018-2029)
1.6.3 Asia-Pacific Nanotechnology Drug Delivery Market Size (2018-2029)
1.6.4 Latin America Nanotechnology Drug Delivery Market Size (2018-2029)
1.6.5 Middle East & Africa Nanotechnology Drug Delivery Market Size (2018-2029)
2 Nanotechnology Drug Delivery Market by Type
2.1 Introduction
2.1.1 Nanocrystals
2.1.2 Nanoparticles
2.1.3 Liposomes
2.1.4 Micelles
2.1.5 Nanotubes
2.1.6 Others
2.2 Global Nanotechnology Drug Delivery Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Nanotechnology Drug Delivery Historic Market Size by Type (2018-2023)
2.2.2 Global Nanotechnology Drug Delivery Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Nanotechnology Drug Delivery Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Nanotechnology Drug Delivery Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Nanotechnology Drug Delivery Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Nanotechnology Drug Delivery Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Nanotechnology Drug Delivery Revenue Breakdown by Type (2018-2029)
3 Nanotechnology Drug Delivery Market Overview by Application
3.1 Introduction
3.1.1 Neurology
3.1.2 Oncology
3.1.3 Cardiovascular/Physiology
3.1.4 Anti-inflammatory/Immunology
3.1.5 Anti-infective
3.1.6 Others
3.2 Global Nanotechnology Drug Delivery Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Nanotechnology Drug Delivery Historic Market Size by Application (2018-2023)
3.2.2 Global Nanotechnology Drug Delivery Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Nanotechnology Drug Delivery Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Nanotechnology Drug Delivery Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Nanotechnology Drug Delivery Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Nanotechnology Drug Delivery Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Nanotechnology Drug Delivery Revenue Breakdown by Application (2018-2029)
4 Nanotechnology Drug Delivery Competition Analysis by Players
4.1 Global Nanotechnology Drug Delivery Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nanotechnology Drug Delivery as of 2022)
4.3 Date of Key Players Enter into Nanotechnology Drug Delivery Market
4.4 Global Top Players Nanotechnology Drug Delivery Headquarters and Area Served
4.5 Key Players Nanotechnology Drug Delivery Product Solution and Service
4.6 Competitive Status
4.6.1 Nanotechnology Drug Delivery Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 AbbVie
5.1.1 AbbVie Profile
5.1.2 AbbVie Main Business
5.1.3 AbbVie Nanotechnology Drug Delivery Products, Services and Solutions
5.1.4 AbbVie Nanotechnology Drug Delivery Revenue (US$ Million) & (2018-2023)
5.1.5 AbbVie Recent Developments
5.2 Amgen
5.2.1 Amgen Profile
5.2.2 Amgen Main Business
5.2.3 Amgen Nanotechnology Drug Delivery Products, Services and Solutions
5.2.4 Amgen Nanotechnology Drug Delivery Revenue (US$ Million) & (2018-2023)
5.2.5 Amgen Recent Developments
5.3 Celgene
5.3.1 Celgene Profile
5.3.2 Celgene Main Business
5.3.3 Celgene Nanotechnology Drug Delivery Products, Services and Solutions
5.3.4 Celgene Nanotechnology Drug Delivery Revenue (US$ Million) & (2018-2023)
5.3.5 Johnson & Johnson Recent Developments
5.4 Johnson & Johnson
5.4.1 Johnson & Johnson Profile
5.4.2 Johnson & Johnson Main Business
5.4.3 Johnson & Johnson Nanotechnology Drug Delivery Products, Services and Solutions
5.4.4 Johnson & Johnson Nanotechnology Drug Delivery Revenue (US$ Million) & (2018-2023)
5.4.5 Johnson & Johnson Recent Developments
5.5 Merck & Co.
5.5.1 Merck & Co. Profile
5.5.2 Merck & Co. Main Business
5.5.3 Merck & Co. Nanotechnology Drug Delivery Products, Services and Solutions
5.5.4 Merck & Co. Nanotechnology Drug Delivery Revenue (US$ Million) & (2018-2023)
5.5.5 Merck & Co. Recent Developments
5.6 Novartis International
5.6.1 Novartis International Profile
5.6.2 Novartis International Main Business
5.6.3 Novartis International Nanotechnology Drug Delivery Products, Services and Solutions
5.6.4 Novartis International Nanotechnology Drug Delivery Revenue (US$ Million) & (2018-2023)
5.6.5 Novartis International Recent Developments
5.7 Perrigo Company
5.7.1 Perrigo Company Profile
5.7.2 Perrigo Company Main Business
5.7.3 Perrigo Company Nanotechnology Drug Delivery Products, Services and Solutions
5.7.4 Perrigo Company Nanotechnology Drug Delivery Revenue (US$ Million) & (2018-2023)
5.7.5 Perrigo Company Recent Developments
5.8 Pfizer
5.8.1 Pfizer Profile
5.8.2 Pfizer Main Business
5.8.3 Pfizer Nanotechnology Drug Delivery Products, Services and Solutions
5.8.4 Pfizer Nanotechnology Drug Delivery Revenue (US$ Million) & (2018-2023)
5.8.5 Pfizer Recent Developments
5.9 Teva Pharmaceutical Industries
5.9.1 Teva Pharmaceutical Industries Profile
5.9.2 Teva Pharmaceutical Industries Main Business
5.9.3 Teva Pharmaceutical Industries Nanotechnology Drug Delivery Products, Services and Solutions
5.9.4 Teva Pharmaceutical Industries Nanotechnology Drug Delivery Revenue (US$ Million) & (2018-2023)
5.9.5 Teva Pharmaceutical Industries Recent Developments
6 North America
6.1 North America Nanotechnology Drug Delivery Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Nanotechnology Drug Delivery Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Nanotechnology Drug Delivery Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Nanotechnology Drug Delivery Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Nanotechnology Drug Delivery Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Nanotechnology Drug Delivery Market Dynamics
11.1 Nanotechnology Drug Delivery Industry Trends
11.2 Nanotechnology Drug Delivery Market Drivers
11.3 Nanotechnology Drug Delivery Market Challenges
11.4 Nanotechnology Drug Delivery Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
